RETA - Reata Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate-1.12-1.22-4.68-4.1
Low Estimate-1.15-1.35-5.09-5.67
High Estimate-1.1-1.1-4.18-1.2
Year Ago EPS-1.08-1.07-2.91-4.68
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate6.84M6.88M28.53M91.09M
Low Estimate5M5M22.73M20M
High Estimate8M8.25M32.52M226.3M
Year Ago Sales7.57M5.17M53.59M28.53M
Sales Growth (year/est)-9.70%32.90%-46.80%219.30%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.73-0.79-1.07-1
EPS Actual-1.08-1.07-0.86-0.98
Difference-0.35-0.280.210.02
Surprise %-47.90%-35.40%19.60%2.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.12-1.22-4.68-4.1
7 Days Ago-1.12-1.22-4.68-4.1
30 Days Ago-1.11-1.22-4.68-3.87
60 Days Ago-1.1-1.19-4.61-3.69
90 Days Ago-1.11-1.18-4.51-3.37
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/AN/AN/A
Up Last 30 Days312N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A111
Growth EstimatesRETAIndustrySectorS&P 500
Current Qtr.-3.70%N/AN/A0.02
Next Qtr.-14.00%N/AN/A0.04
Current Year-60.80%N/AN/A0.05
Next Year12.40%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A